Understanding the role of the AhR/AhRR/CYP1A1 axis in lung cancer progression is of importance to improve current therapeutic approaches and develop new therapeutic strategies for the treatment of NSCLC. The gene discussed is CYP1A1; the disease is non-small cell lung carcinoma.